Results of the PI3K delta inhibitor ME-401 alone or with rituximab in relapsed/refractory (R/R) follicular lymphoma (FL) Meeting Abstract

  

Authors:	Zelenetz, A. D.; Jagadeesh, D.; Reddy, N. M.; Stathis, A.; Salman, H. S.; Asch, A. S.; Kenkre, V. P.; Jhangiani, H. S.; Iasonos, A.; Soumerai, J. D.; Llorin, J.; Pagel, J. M.
Abstract Title:	Results of the PI3K delta inhibitor ME-401 alone or with rituximab in relapsed/refractory (R/R) follicular lymphoma (FL)
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	427s
Language:	English
ACCESSION:	WOS:000487345806274
PROVIDER:	wos
DOI:	10.1200/JCO.2019.37.15_suppl.7512
Notes:	Meeting Abstract: 7512 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156498